During the past decade, Gundersen Lutheran Center for Cancer and Blood conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 55 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gundersen Lutheran Center for Cancer and Blood" #1 sponsor was "Eastern Cooperative Oncology Group" with 30 trials, followed by "Radiation Therapy Oncology Group" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 22 trials sponsored, "SWOG Cancer Research Network" with 16 trials sponsored and "Children's Oncology Group" with 16 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gundersen Lutheran Center for Cancer and Blood" #1 collaborator was "National Cancer Institute (NCI)" with 125 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 10 trials as a collaborator and "North Central Cancer Treatment Group" with 7 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Gundersen Lutheran Center for Cancer and Blood" are "Breast Cancer" (24 trials), "Lung Cancer" (21 trials), "Lymphoma" (11 trials), "Leukemia" (10 trials) and "Prostate Cancer" (10 trials). Many other conditions were trialed in "Gundersen Lutheran Center for Cancer and Blood" in a lesser frequency.

Most popular intervention types in "Gundersen Lutheran Center for Cancer and Blood" are "Drug" (107 trials), "Radiation" (49 trials), "Biological" (43 trials), "Procedure" (29 trials) and "Other" (20 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (26 trials), "cyclophosphamide" (22 trials), "filgrastim" (15 trials), "paclitaxel" (15 trials) and "carboplatin" (14 trials). Other intervention names were less common.

The vast majority of trials in "Gundersen Lutheran Center for Cancer and Blood" are 100 trials for "All" genders, 22 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Gundersen Lutheran Center for Cancer and Blood". undefined are not yet recruiting, undefined are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 106 completed trials in Gundersen Lutheran Center for Cancer and Blood, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Gundersen Lutheran Center for Cancer and Blood, 6 "Phase 1" clinical trials were conducted, 55 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".